Saarinen, Aino http://orcid.org/0000-0003-4495-8360
Keltikangas-Järvinen, Liisa
Viding, Essi
Dobewall, Henrik
Kaseva, Kaisa
Lehtimäki, Terho
Raitakari, Olli
Hintsanen, Mirka
Funding for this research was provided by:
Academy of Finland (308676, 322098; 286284; 134309 (Eye); 126925; 121584; 124282; 129378 (Salve); 117787 (Gendi); 41071 (Skidi))
Competitive State Research Financing of the Expert Respnsibility area of Kuopio, Tampere and Turku University Hospitals (X51001)
the Social Insurance Institution of Finland (-)
Juho Vainio Foundation (-)
Paavo Nurmi Foundation (-)
Finnish Foundation for Cardiovascular Research (-)
Finnish Cultural Foundation (-)
The Sigrid Juselius Foundation (-)
Tampere Tuberculosis Foundation (-)
Emil Aaltosen Säätiö (-)
Yrjö Jahnsson Foundation (-)
Signe ja Ane Gyllenbergin Säätiö (-)
Diabetes Research Foundation of Finnish Diabetes Association (-)
EU Horizon 2020 (grant 755320 for TAXINOMISIS and grant 848146 for To Aition)
European Research Council (grant 742927 for MULTIEPIGEN project)
Tampere University Hospital Supporting Foundation (-)
Finnish Society of Clinical Chemistry (-)
University of Helsinki including Helsinki University Central Hospital
Article History
Accepted: 2 March 2021
First Online: 13 April 2021
Compliance with ethical standards
:
: The authors have no relevant financial or non-financial interests to disclose.
: The study was carried out in accordance with the Declaration of Helsinki. Additionally, all the Finnish universities with medical schools approved the study design. Before participation, all the participants or their parents (for participants aged below 12 years) provided written informed consent after the nature of the procedures had been fully explained.